- Akebia Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Akebia Therapeutics Inc Earnings Call TranscriptNov 08, 2023€0.953 (-4.60%)Earnings
- Q2 2023 Akebia Therapeutics Inc Earnings Call TranscriptAug 25, 2023€1.06 (-7.97%)Earnings
- Akebia Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Akebia Therapeutics Inc To Discuss The Response To The FDRR TranscriptMay 30, 2023
- Q1 2023 Akebia Therapeutics Inc Earnings Call TranscriptMay 08, 2023€0.934 (+12.26%)Earnings
- Akebia Therapeutics Inc to Host Stockholder Information Session TranscriptApr 21, 2023
- Q4 2022 Akebia Therapeutics Inc Earnings Call TranscriptMar 09, 2023€0.744 (-23.72%)Earnings
- Q3 2022 Akebia Therapeutics Inc Earnings Call TranscriptNov 03, 2022€0.252 (-3.89%)Earnings
- Q2 2022 Akebia Therapeutics Inc Earnings Call TranscriptAug 04, 2022€0.3854 (+4.99%)Earnings
- Q1 2022 Akebia Therapeutics Inc Earnings Call TranscriptMay 09, 2022€0.3351 (+24.71%)Earnings
- Akebia Therapeutics Inc Corporate Call TranscriptMar 30, 2022
- Akebia Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Akebia Therapeutics Inc Earnings Call TranscriptNov 09, 2021€2.44 (-0.81%)Earnings
- Akebia Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Akebia Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Akebia Therapeutics Inc Earnings Call TranscriptAug 05, 2021€2.38 (+13.33%)Earnings
- Akebia Therapeutics Inc Annual Shareholders Meeting TranscriptJun 02, 2021
- Q1 2021 Akebia Therapeutics Inc Earnings Call TranscriptMay 10, 2021€2.42 (-5.47%)Earnings
- Q4 2020 Akebia Therapeutics Inc Earnings Call TranscriptFeb 25, 2021€3.44 (+1.78%)Earnings
- Akebia Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Akebia Therapeutics Inc Earnings Call TranscriptNov 05, 2020€2.1 (+1.94%)Earnings
- Akebia to Present Global Phase 3 Vadadustat Data at American Society of Nephrology Kidney Week 2020 Reimagined TranscriptOct 23, 2020
- Akebia Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Akebia Therapeutics Inc Conference Call and Live Webcast to Discuss the PRO(2)TECT Data TranscriptSep 03, 2020
- Akebia Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Q1 2020 Akebia Therapeutics Inc Earnings Call TranscriptMay 05, 2020Earnings
- Q4 2019 Akebia Therapeutics Inc Earnings Call TranscriptMar 10, 2020Earnings
- Akebia Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Akebia Therapeutics Inc Earnings Call TranscriptNov 12, 2019Earnings
- Akebia Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Akebia Therapeutics Inc Earnings Call TranscriptAug 08, 2019Earnings
- Q1 2019 Akebia Therapeutics Inc Earnings Call TranscriptMay 09, 2019Earnings
- Q4 2018 Akebia Therapeutics Inc Earnings Call TranscriptMar 18, 2019Earnings
Akebia Therapeutics Inc Conference Call and Live Webcast to Discuss the PRO(2)TECT Data Transcript
Welcome to Akebia Therapeutics PRO2TECT top line data readout call. As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Kristen Sheppard.
Thank you, and good morning. My name is Kristen Sheppard, Senior Vice President of Investor Relations of Akebia. Thank you for joining us to discuss Akebia's top line data from PRO2TECT, the second of our 2 global Phase III cardiovascular outcomes program, evaluating vadadustat for the treatment of anemia due to chronic kidney disease.
We issued a press release containing this top line data this morning. It is also available on our Investor Relations website, along with the slides for today's call. For your convenience, an audio replay of today's call and the slides will also be available on our website shortly after we conclude today's webcast.
Joining our call today are John Butler, our President and Chief Executive Officer, and Dr. Steven Burke, our Chief Medical Officer.
Before we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)